Pharmacological Advances in Natural Product Drug Discovery
141,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

Pharmacological Advances in Natural Product Drug Discovery, Volume 87 in the Advances in Pharmacology series, presents the latest pharmacological research progresses of 8 medicinal compounds from natural products, including salvianolic acid, tanshinone, paeonol, chlorogenic acid, astragaloside, icariin, ganoderan, and febrifugine. Specific chapters to this new release include Potential Role of Paeonol on Atherosclerosis Related Cells, A Review on Salvianolic Acid, Pharmacological Advances of Tanshinones, the Natural Product of Salvia Miltiorrhiza, Pharmacological Action and Potential Targets…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Pharmacological Advances in Natural Product Drug Discovery, Volume 87 in the Advances in Pharmacology series, presents the latest pharmacological research progresses of 8 medicinal compounds from natural products, including salvianolic acid, tanshinone, paeonol, chlorogenic acid, astragaloside, icariin, ganoderan, and febrifugine. Specific chapters to this new release include Potential Role of Paeonol on Atherosclerosis Related Cells, A Review on Salvianolic Acid, Pharmacological Advances of Tanshinones, the Natural Product of Salvia Miltiorrhiza, Pharmacological Action and Potential Targets Analysis of Major Pharmacological Effects of Chlorogenic Acid, Modern TCM: Identifying and Defining the "Medicinal Mix", Pharmacological Advances in Astragaloside IV Derived from Astragalus Membranaceus, and much more.
Autorenporträt
Guanhua Du is a professor of Pharmacology; Former-President of the Chinese Pharmacological Society; a member of the Asia Pacific Federation of Pharmacologists Executive Committee; and Director of National Centre for Pharmaceutical Screening.
Dr. Du got his Ph.D. degree from Peking Union Medical College in 1995, and conducted his postdoctoral research in University of Liege, Belgium from 1995 to 1998. Dr. Du is mainly engaged in drug discovery and development, screening methods and strategy, and drug effect and mechanism research in cerebrovascular and neurodegenerative disease. He originated the national high-throughput drug screening system in China, and provided drug screening services for over 300 million numbers of samples for domestic pharmaceutical institutions or enterprises.
In the recent 10 years, Dr. Du has published more than 400 papers, discovered more than 30 monographs, and applied for more than 60 patents. He has finished preclinical research of 3 new drugs. H

e is the member of editorial committee of "Pharmacology & Therapeutics? and more than ten other journals.